EN
中文 EN
Newsroom
Company News
Media Report
Company News
More
2026-08-28
CanSinoBIO Expands Innovative Product Portfolio as Internationalization Enters a New Phase — CEO Dr. Xuefeng Yu Speaks with Bloomberg TV
CanSinoBIO Shares Perspectives on the Future of Vaccine Manufacturing at 27th DCVMN Annual General Meeting
2026-09-23
CanSinoBIO and deepGeneAI Explore Collaboration in Personalized mRNA Cancer Vaccines
2026-08-25
CanSinoBIO Showcases Innovative Vaccine Practices at the 12th Asian Congress of Pediatric Infectious Diseases
2026-08-18
CanSinoBIO's Td5cp Vaccine for Adolescents and Adults NDA Accepted by China's NMPA
2026-08-16
CanSinoBIO Signs PCV13i LOI with Pakistani Partner to Expand Vaccine Collaboration in South Asia
2026-07-21
Media Report
More
[YiCai GLOBAL] Connecting Innovation and Global Markets: Jeanne Wang on CanSinoBIO’s Next Stage of Growth
Time：2026-09-24
More
Revenue Soars with 137% Year-on-Year Growth, Multiple Products Poised for Launch, CanSinoBIO's Growth Momentum Strong
Time：2025-03-28
More
CanSinoBIO to Showcase China’s Vaccine Innovation at 2025 World Government Summit in Dubai
Time：2025-02-14
More